Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway The agency has taken heat for not showing enough flexibility. In this case, it showed too much

https://www.statnews.com/2026/04/16/travere-therapeutics-kidney-disease-fda-approval/ By Adam FeuersteinApril 16, 2026 Senior Writer, Biotech